Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
The New Zealand Medical Journal|March 22, 2005
Findings and outcome of teenage women referred for colposcopy at Christchurch Women's Hospital, New ZealandPeter Sykes, Dianne Harker, David PeddieInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 7, 2022
Use of direct oral anticoagulants for postoperative venous thromboembolism prophylaxis after surgery for gynecologic malignanciesMarilyn Boo, Peter Sykes, Bryony SimcockNanotechnology|July 26, 2016
Seed mediated synthesis of highly mono-dispersed gold nanoparticles in the presence of hydroquinoneDhiraj Kumar, Isha Mutreja, Peter SykesAfrican Journal of Reproductive Health|March 23, 2018
Exploring the Barriers to Breast and Cervical Cancer Screening in Nigeria: A Narrative ReviewAisha M Dodo, Peter Sykes, Colin PowellThe Australian & New Zealand Journal of Obstetrics & Gynaecology|December 16, 2004
Is there a role for colposcopy in the follow-up of treated low grade squamous intraepithelial lesions?Simon Jones, Peter Sykes, Selvan Pather, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 21, 2005
Postpartum curettage: an audit of 200 casesSelvan Pather, Monica Ford, Rosemary Reid, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 21, 2005
Human papilloma virus is detectable by the Hybrid Capture 2 test in cervical smear samples from women over 40 years of age with high-grade squamous intraepithelial lesionsPeter Sykes, Lance Jennings, Dianne Harker, et al.Nanotechnology|October 14, 2017
Cytotoxicity and cellular uptake of different sized gold nanoparticles in ovarian cancer cellsDhiraj Kumar, Isha Mutreja, Kenny Chitcholtan, et al.The Journal of Obstetrics and Gynaecology Research|August 11, 2023
Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancerIrfan Yunianto, Margaret Currie, Kenny Chitcholtan, et al.Cancers|January 21, 2022
The Anti-Proliferative Effect of PI3K/mTOR and ERK Inhibition in Monolayer and Three-Dimensional Ovarian Cancer Cell ModelsElizabeth Dunn, Kenny Chitcholtan, Peter Sykes, et al.Pageof 8